Adverse effects on mother and child: CTG group II fetal heart change was 20%, uterine hyperstimulation accounted for 13.1%, followed by rupture of amniotic sac 9.4%, postpartum haemorrhage 2.5%, jaundice 1.3% and neonatal infection 0.6%, no respiratory failure.